These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2128341)

  • 21. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguchi O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Aug; 59(4):217-315. PubMed ID: 17111595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
    Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
    Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gentamicin susceptibility of gram-negative problem germs and staphylococci, indicated by the tube dilution method].
    Modde H
    Pathol Microbiol (Basel); 1972; 38(4):286-95. PubMed ID: 4565703
    [No Abstract]   [Full Text] [Related]  

  • 26. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. III].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jun; 38(6):1603-18. PubMed ID: 3930806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of antimicrobial agents and antineoplastic agents.
    Yamashiro Y; Fukuoka Y; Yotsuji A; Yasuda T; Saikawa I; Ueda Y
    J Antimicrob Chemother; 1986 Dec; 18(6):703-8. PubMed ID: 3102447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan.
    Araoka H; Baba M; Tateda K; Ishii Y; Oguri T; Okuzumi K; Oishi T; Mori S; Mitsuda T; Moriya K; Nakamori Y; Ohmagari N; Yamaguchi K; Yoneyama A;
    Jpn J Infect Dis; 2012; 65(1):84-7. PubMed ID: 22274165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 31. Aminoglycoside antibiotics. V. The 4'-deoxybutirosins (Bu-1975C1 and C2), new aminoglycoside antibiotics of bacterial origin.
    Kawaguchi H; Tomita K; Hoshiya T; Miyaki T; Fujisawa K
    J Antibiot (Tokyo); 1974 Jun; 27(6):460-70. PubMed ID: 4211790
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and laboratory studies with tobramycin.
    Geddes AM; Goodall JA; Speirs CF; Gillett AP; Andrews J; Williams JD
    Chemotherapy; 1974; 20(4):245-56. PubMed ID: 4212996
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microbiology of gentamicin resistance.
    Weinstein MJ
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:99-1. PubMed ID: 4205065
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
    Flynn CM; Johnson DM; Jones RN
    J Chemother; 1996 Dec; 8(6):411-5. PubMed ID: 8981179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection].
    Sonoda T; Nakano E; Seguchi T; Yano H; Kuroda H; Ihara Y; Kishimoto T; Takatera H; Mizutani S; Iwao N
    Hinyokika Kiyo; 1991 Feb; 37(2):203-9. PubMed ID: 2048503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin.
    Medeiros AA; O'Brien TF; Wacker WE; Yulug NF
    J Infect Dis; 1971 Dec; 124 Suppl():S59-64. PubMed ID: 5001630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.